Oncolytics Biotech, Inc. (ONCY)
0.8566
-0.02
(-2.66%)
USD |
NASDAQ |
Sep 03, 16:00
0.8566
0.00 (0.00%)
After-Hours: 19:10
Oncolytics Biotech Net Income (Annual) : -28.76M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -28.76M |
| December 31, 2024 | -22.79M |
| December 31, 2023 | -20.56M |
| December 31, 2022 | -19.08M |
| December 31, 2021 | -20.98M |
| December 31, 2020 | -16.78M |
| December 31, 2019 | -24.96M |
| December 31, 2018 | -13.14M |
| December 31, 2017 | -12.03M |
| December 31, 2016 | -11.43M |
| December 31, 2015 | -10.73M |
| December 31, 2014 | -16.86M |
| December 31, 2013 | -22.84M |
| December 31, 2012 | -36.39M |
| Date | Value |
|---|---|
| December 31, 2011 | -29.36M |
| December 31, 2010 | -23.94M |
| December 31, 2009 | -14.23M |
| December 31, 2008 | -16.45M |
| December 31, 2007 | -14.86M |
| December 31, 2006 | -12.61M |
| December 31, 2005 | -10.55M |
| December 31, 2004 | -9.956M |
| December 31, 2003 | -6.101M |
| December 31, 2002 | -3.879M |
| December 31, 2001 | -3.985M |
| December 31, 2000 | -2.432M |
| December 31, 1999 | -0.3867M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 30.11M |
| Sangamo Therapeutics, Inc. | -122.93M |
| Sarepta Therapeutics, Inc. | -713.41M |
| Anixa Biosciences, Inc. | -11.03M |
| Vicapsys Life Sciences, Inc. | -0.6899M |